Drug Interactions between brivaracetam and Protonix IV
This report displays the potential drug interactions for the following 2 drugs:
- brivaracetam
- Protonix IV (pantoprazole)
Interactions between your drugs
pantoprazole brivaracetam
Applies to: Protonix IV (pantoprazole) and brivaracetam
According to the manufacturer, brivaracetam is a weak inhibitor of CYP450 2C19 in vitro and is not expected to cause significant inhibition of CYP450 2C19 in humans. No precaution is necessary when brivaracetam is coadministered with CYP450 2C19 substrates.
References (2)
- Cerner Multum, Inc. "UK Summary of Product Characteristics."
- (2016) "Product Information. Briviact (brivaracetam)." UCB Pharma Inc
Drug and food interactions
No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.